Suppr超能文献

术前使用阿片类药物对踝关节骨折手术后并发症、再入院和费用的影响。

The impact of preoperative opioid use on complications, readmission, and cost following ankle fracture surgery.

机构信息

Emory University Department of Orthopaedics, 59 Executive Park South, Suite 200, Atlanta, GA 30329, United States.

出版信息

Injury. 2021 Aug;52(8):2469-2474. doi: 10.1016/j.injury.2021.05.011. Epub 2021 May 19.

Abstract

BACKGROUND

The incidence of ankle fractures requiring surgical fixation is increasing. Although there has been increasing evidence to suggest that preoperative opioid use negatively impacts surgical outcomes, literature focusing primarily on ankle fractures is scarce. The purpose of this study was to investigate the relationship between preoperative opioid use and outcomes following ankle fracture open reduction and surgical fixation (ORIF). We hypothesized that patients prescribed higher preoperative oral morphine equivalents (OMEs) would have poorer postoperative outcomes.

METHODS

The Truven Marketscan claims database was used to identify patients who underwent ankle fracture surgery from 2009 to 2018 based on CPT codes. We used preoperative opioid use status to divide patients into groups based on the average daily OMEs consumed in the 6 months before surgery: opioid-naive,<1, 1-<5, 5-<10, and ≥10 OMEs per day. We retrieved 90-day complication, ER visit, and readmission rates. Opioid use groups were then compared with binomial logistic regression and generalized linear models.

RESULTS

We identified 61,424 patients. Of those patients, 80.9% did not receive any preoperative opioids, while 6.6%, 6.9%, 1.7%, and 3.9% received <1, 1-<5, 5-<10, and ≥10 OMEs per day over a 6-month time period, respectively. Complications increased with increasing preoperative OMEs. Multivariate analysis revealed that patients using 1-<5 OME per day had increased rates of VTE and infections, while patients using >5 OME per day had higher rates of ED visits, and patients using >10 OMEs had higher rates of pain related ED visits and readmissions. Adjusted differences in 6-month preoperative and 3-month postoperative health care costs were seen in the opioid use groups compared with opioid-naive patients, ranging from US$2052 to US$8,592 (P<.001).

CONCLUSION

Opioids use prior to ankle fracture surgery is a common scenario. Unfortunately preoperative opioid use is a risk factor for postoperative complications, ER visits, and readmissions. Furthermore this risk is greater with higher dose opioid use. The results of this study suggests that surgeons should encourage decreased opioid use prior to ankle fracture surgery.

摘要

背景

需要手术固定的踝关节骨折发病率正在上升。尽管越来越多的证据表明术前使用阿片类药物会对手术结果产生负面影响,但主要关注踝关节骨折的文献却很少。本研究旨在探讨术前使用阿片类药物与踝关节骨折切开复位内固定术(ORIF)后的结果之间的关系。我们假设,接受更高术前口服吗啡等效物(OME)处方的患者术后结局较差。

方法

使用 Truven Marketscan 索赔数据库,根据 CPT 代码,从 2009 年至 2018 年确定接受踝关节骨折手术的患者。我们根据术前 6 个月内消耗的平均每日 OME 将患者分为以下几组:阿片类药物未使用者、<1、1-<5、5-<10 和≥10 OME/天。我们检索了 90 天内的并发症、急诊就诊和再入院率。然后使用二项逻辑回归和广义线性模型对阿片类药物使用组进行比较。

结果

我们确定了 61424 名患者。其中 80.9%的患者未接受任何术前阿片类药物治疗,而 6.6%、6.9%、1.7%和 3.9%的患者在 6 个月的时间内分别接受<1、1-<5、5-<10 和≥10 OME/天的治疗。并发症随着术前 OME 的增加而增加。多变量分析显示,每天使用 1-<5 OME 的患者发生 VTE 和感染的几率增加,而每天使用>5 OME 的患者急诊就诊的几率增加,每天使用>10 OME 的患者与疼痛相关的急诊就诊和再入院的几率增加。与阿片类药物未使用者相比,在阿片类药物使用组中观察到 6 个月术前和 3 个月术后医疗保健费用的调整差异,范围为 2052 美元至 8592 美元(P<.001)。

结论

术前踝关节骨折手术前使用阿片类药物是一种常见现象。不幸的是,术前使用阿片类药物是术后并发症、急诊就诊和再入院的危险因素。此外,随着阿片类药物剂量的增加,这种风险更大。本研究结果表明,外科医生应鼓励减少踝关节骨折术前阿片类药物的使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验